Mastercard has launched an early-access program for its Agent Pay for Machines API, enabling AI-driven payments across card, bank, and stablecoin networks. This initiative follows successful pilot programs with companies like Coinbase, Base, and Cloudflare. In a separate development, OpenAI has acquired Orchestra Bio, integrating its AI agents into Rosalind to assist drug companies with managing intricate development timelines. AI
IMPACT Mastercard's API could streamline AI-driven transactions, while OpenAI's acquisition aims to accelerate drug development through AI.
RANK_REASON The cluster contains two distinct announcements: a product launch by Mastercard and an acquisition by OpenAI, neither of which are frontier AI releases or significant industry shifts.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →